Search

everythinglearnresearchcommunity

for

Search:↓

Behavior therapy and medications, especially clomipramine, can help reduce hair pulling in people with trichotillomania.

COVID-19 can cause various skin issues, including rashes and hair loss, which usually heal on their own and don't always indicate severe illness.

Treatment can improve survival and symptoms in dogs with Cushing's disease, but outcomes are unpredictable.

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

Men, diabetes, and high inflammation levels lead to higher COVID-19 antibodies.

Wait 3 months after COVID-19 before trying assisted reproduction and further research is needed on COVID-19's effects on male hormones and fertility.

Testosterone replacement therapy should be used for men with low testosterone levels and symptoms of hypogonadism, after careful diagnosis and considering individual needs.

Treatment with dutasteride, minoxidil, and artificial hair transplantation improved appearance but caused folliculitis.

Patients with chronic renal failure on hemodialysis often have skin problems like dry skin, itching, and nail changes.

Hair from people with seborrheic dermatitis is thicker scaled, more damaged, and thinner than healthy hair, and atomic force microscopy can help monitor the condition.

Early treatment with immunoglobulin and aspirin reduces heart complications in children with Kawasaki disease.

The new visual scale is a quick and effective way to measure hair loss in women.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

Finasteride and dutasteride are effective for long-term treatment of enlarged prostates but have sexual side effects and a risk of high-grade prostate cancer.

Pranic meditation significantly improved mental health and quality of life for breast cancer survivors.

New treatments for PCOS focus on managing symptoms and improving fertility.

THAP1 gene changes do not affect DYT1 dystonia; finasteride may help reduce tics and OCD in Tourette syndrome.

The document says PCOS is a common hormonal disorder in women, diagnosed by certain criteria, and managed with lifestyle changes and various medications.

The document concludes that managing PCOS involves treating symptoms and reducing long-term metabolic risks, with lifestyle changes being important.

Most women with PCOS use positive coping strategies, but some with more psychological stress use negative ones.

Hormone therapy may increase migraines in transgender women and decrease them in transgender men; more research is needed on migraine management in transgender individuals.

Most hospitalized internal medicine patients have undiagnosed skin problems and want them treated.

A specific gene mutation is linked to a hereditary form of dystonia that responds well to certain medications.

Obesity is linked to skin conditions like acanthosis nigricans and skin tags, which may indicate high insulin levels.

A man's unusual scalp folds caused by a skin condition were treated with surgery and remained unchanged two years later.

Many adult women suffer from persistent or late-onset acne, and while various treatments exist, finding the right one can be challenging.

New acne treatments include combination creams, advanced retinoids, and light therapies, focusing on safety and patient adherence.

Pregnancy right after giving birth in mice lacking IL-10 causes milk that leads to liver issues and hair loss in their babies.

A woman's unique dementia was misdiagnosed, a genetic mutation increases Parkinson's risk with age, and finasteride may help with Tourette syndrome.

The main goal for new Alopecia Areata treatments should be significant improvement in scalp hair growth.